NCT07749950Active, not recruiting
Effects of Early Mobilization and Feeding After Lobectomy
The Effect of Early Nutrition and Mobilization From ERAS Protocols on Patient Outcomes in Lung Cancer Patients Undergoing Lobectomy
Source: ClinicalTrials.gov · Last updated 7 Aug 2026
Brief summary (registry, in English)
This randomized controlled study evaluates the effects of early mobilization and early oral feeding, two components of the Enhanced Recovery After Surgery (ERAS) protocol, on postoperative outcomes in adult patients with lung cancer undergoing lobectomy at Ege University Hospital. Participants were randomly assigned to an intervention group or a control group. In addition to standard postoperative care, participants in the intervention group received an ERAS-based protocol consisting of sitting at the bedside approximately 5.5 hours after surgery, beginning mobilization at 6 hours, and walking at least 100 meters when clinically stable and approved by the surgical team. Oral water intake was started at 6 hours, followed by a full liquid diet at 7 hours and gradual transition to a regular diet at 12 hours if tolerated. Participants in the control group received the clinic's standard postoperative care. The study compares postoperative pain, complications, chest tube duration, length of hospital stay, reoperation, readmission within 30 days, nutritional status, laboratory findings, and quality of life between the two groups. Participants are followed for up to three months after surgery.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 3 Aug 2026
- Start date
- May 2026
- Primary completion date
- Oct 2026
- Lead sponsor
- Ege University
- Diseases
- Lung cancer
- NCT number
- NCT07749950
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From May 2026 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Requirement for emergency surgery
Other illness
- Metastatic disease
- Severe uncontrolled comorbid disease, including:
- Cardiac failure
- Renal failure
- Hepatic failure
- History of cranial trauma
- Neurological conditions, including:
- Local peripheral neuropathy
- Central nervous system disease
- Impairment affecting participation, including:
- Cognitive impairment
- Communication impairment
Other
- Requirement for mechanical ventilation for 24 hours or longer
- Requirement for prolonged bed rest
Who the study is looking for
- Age 18 years or older
- Diagnosis or suspected diagnosis of lung cancer, including:
- Histologically or cytologically confirmed lung cancer
- Radiologically suspected lung cancer pending pathological confirmation
- Scheduled to undergo lobectomy
- Eastern Cooperative Oncology Group (ECOG) performance status of:
- ECOG 0
- ECOG 1
- Ability and willingness to participate, including:
- Voluntary agreement to participate
- Ability to provide written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ege University Hospital, Department of Thoracic Surgery Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.